交易 Kintara Therapeutics, Inc. - KTRA CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.05 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Nov 29, 2023 | 0.39 | 0.01 | 2.63% | 0.38 | 0.46 | 0.38 |
Nov 10, 2023 | 0.38 | 0.00 | 0.00% | 0.38 | 0.65 | 0.38 |
Nov 9, 2023 | 0.38 | -0.02 | -5.00% | 0.40 | 0.40 | 0.37 |
Nov 8, 2023 | 0.39 | -0.02 | -4.88% | 0.41 | 0.41 | 0.39 |
Nov 7, 2023 | 0.41 | -0.01 | -2.38% | 0.42 | 0.42 | 0.38 |
Nov 6, 2023 | 0.40 | -0.03 | -6.98% | 0.43 | 0.43 | 0.38 |
Nov 3, 2023 | 0.41 | 0.00 | 0.00% | 0.41 | 0.46 | 0.40 |
Nov 2, 2023 | 0.38 | -0.10 | -20.83% | 0.48 | 0.48 | 0.38 |
Nov 1, 2023 | 0.48 | -0.22 | -31.43% | 0.70 | 0.70 | 0.46 |
Oct 31, 2023 | 0.73 | -0.22 | -23.16% | 0.95 | 1.08 | 0.71 |
Oct 30, 2023 | 3.72 | -0.04 | -1.06% | 3.76 | 3.88 | 3.62 |
Oct 27, 2023 | 4.11 | 0.14 | 3.53% | 3.97 | 4.32 | 3.97 |
Oct 26, 2023 | 4.08 | -0.10 | -2.39% | 4.18 | 4.34 | 4.08 |
Oct 25, 2023 | 3.87 | -0.31 | -7.42% | 4.18 | 4.18 | 3.74 |
Oct 24, 2023 | 4.10 | -0.18 | -4.21% | 4.28 | 4.28 | 4.08 |
Oct 23, 2023 | 4.17 | 0.22 | 5.57% | 3.95 | 4.32 | 3.74 |
Oct 20, 2023 | 3.97 | 0.00 | 0.00% | 3.97 | 4.30 | 3.97 |
Oct 19, 2023 | 4.26 | 0.08 | 1.91% | 4.18 | 4.47 | 4.17 |
Oct 18, 2023 | 4.04 | 0.36 | 9.78% | 3.68 | 4.07 | 3.68 |
Oct 17, 2023 | 3.69 | 0.07 | 1.93% | 3.62 | 3.70 | 3.60 |
Kintara Therapeutics, Inc. Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
沒有活動安排 |
- 每年
- 每季度
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
總營業費用 | 38.166 | 9.19824 | 8.3985 | 11.1747 | 8.32083 |
銷售/一般/行政費用,總計 | 9.757 | 4.51452 | 4.73644 | 3.82753 | 3.34785 |
研究與開發 | 27.909 | 3.63002 | 3.66206 | 7.34714 | 4.97298 |
營業收入 | -38.166 | -9.19824 | -8.3985 | -11.1747 | -8.32083 |
利息收入(費用),非經營淨值 | -0.132 | 0.07233 | 0.47646 | 0.03635 | 0.23907 |
稅前淨收入 | -38.298 | -9.12592 | -8.04822 | -11.1383 | -8.08176 |
稅後淨收入 | -38.298 | -9.12592 | -8.04822 | -11.1383 | -8.08176 |
未計算非常項目前的淨收益 | -38.298 | -9.12592 | -8.04822 | -11.1383 | -8.08176 |
淨收入 | -38.298 | -9.12592 | -8.04822 | -11.1383 | -8.08176 |
Total Adjustments to Net Income | -3.206 | -0.00862 | -0.08043 | -0.17624 | -0.79045 |
普通股股東可獲收益 (不含非經常性項目) | -41.504 | -9.13453 | -8.12865 | -11.3146 | -8.87222 |
普通股股東可獲收益 (含非經常性項目) | -41.504 | -9.13453 | -8.12865 | -11.3146 | -8.87222 |
攤薄淨收入 | -41.504 | -9.13453 | -8.12865 | -11.3146 | -8.87222 |
攤薄後加權平均股 | 25.886 | 10.444 | 2.57469 | 2.08614 | 1.20471 |
扣除特別項目的每股攤薄盈利 | -1.60334 | -0.87462 | -3.15714 | -5.42367 | -7.36462 |
Dividends per Share - Common Stock Primary Issue | |||||
每股正常攤薄盈利 | -1.58402 | -0.77373 | -3.15714 | -5.42367 | -7.36462 |
其他,淨值 | -0.12619 | ||||
異常費用(收入) | 0.5 | 1.0537 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
總營業費用 | 5.358 | 5.895 | 5.971 | 6.697 | 6.605 |
銷售/一般/行政費用,總計 | 1.884 | 1.993 | 2.178 | 2.666 | 2.762 |
研究與開發 | 3.474 | 3.902 | 3.793 | 4.031 | 3.843 |
異常費用(收入) | 0 | 0 | 0 | 0 | 0 |
營業收入 | -5.358 | -5.895 | -5.971 | -6.697 | -6.605 |
利息收入(費用),非經營淨值 | 0.002 | 0.002 | 0.005 | -0.035 | -0.03 |
稅前淨收入 | -5.356 | -5.893 | -5.966 | -6.732 | -6.635 |
稅後淨收入 | -5.356 | -5.893 | -5.966 | -6.732 | -6.635 |
未計算非常項目前的淨收益 | -5.356 | -5.893 | -5.966 | -6.732 | -6.635 |
淨收入 | -5.356 | -5.893 | -5.966 | -6.732 | -6.635 |
Total Adjustments to Net Income | -0.002 | -0.002 | -2.464 | -0.004 | -0.008 |
普通股股東可獲收益 (不含非經常性項目) | -5.358 | -5.895 | -8.43 | -6.736 | -6.643 |
普通股股東可獲收益 (含非經常性項目) | -5.358 | -5.895 | -8.43 | -6.736 | -6.643 |
攤薄淨收入 | -5.358 | -5.895 | -8.43 | -6.736 | -6.643 |
攤薄後加權平均股 | 49.128 | 48.529 | 34.281 | 32.441 | 29.273 |
扣除特別項目的每股攤薄盈利 | -0.10906 | -0.12147 | -0.24591 | -0.20764 | -0.22693 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.10906 | -0.12147 | -0.24591 | -0.20764 | -0.22693 |
- 每年
- 每季度
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
流動資産總額 | 11.793 | 2.85108 | 4.02519 | 7.04644 | 7.87073 |
現金和短期投資 | 10.537 | 2.3924 | 3.71876 | 5.972 | 6.58601 |
現金等價物 | 10.537 | 2.3924 | 3.71876 | 5.972 | |
應收賬款總額,淨額 | 0.0094 | 0.02619 | 0.03952 | 0.0766 | |
預付的費用 | 0.756 | 0.35558 | 0.28025 | 1.03493 | 1.20812 |
其他流動資産,總計 | 0.5 | 0.0937 | |||
總資産 | 13.543 | 2.93814 | 4.03726 | 7.07486 | 7.91102 |
無形資産,淨額 | 0.00211 | 0.01206 | 0.02841 | 0.04029 | |
流動負債總額 | 2.78 | 2.67492 | 2.06973 | 1.63852 | 1.30436 |
Payable/Accrued | 2.219 | 2.01106 | 1.74452 | 1.47809 | 1.18231 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 0.561 | 0.66387 | 0.32521 | 0.16043 | 0.12205 |
負債總額 | 2.962 | 2.67492 | 2.06973 | 1.63963 | 1.3325 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
其他負債,總計 | 0.182 | 0 | 0.00112 | 0.02814 | |
股權 | 10.581 | 0.26321 | 1.96753 | 5.43522 | 6.57852 |
Preferred Stock - Non Redeemable, Net | 14.931 | 4.80343 | 4.97783 | 6.42541 | 6.42541 |
普通股 | 0.033 | 0.01146 | 0.00384 | 0.02297 | 0.01451 |
額外實收資本 | 106.821 | 56.6241 | 50.9547 | 43.1775 | 36.6653 |
留存收益(累計赤字) | -111.225 | -61.1969 | -53.9901 | -44.2119 | -36.5479 |
其他權益,總計 | 0.021 | 0.02118 | 0.02118 | 0.02118 | 0.02118 |
總負債和股東權益 | 13.543 | 2.93814 | 4.03726 | 7.07486 | 7.91102 |
已發行普通股總數 | 32.74 | 11.4579 | 3.83936 | 2.29667 | 1.45096 |
Total Preferred Shares Outstanding | 0.279 | 0.92714 | 0.95214 | 1.15964 | 1.15964 |
現金 | 6.58601 | ||||
其他長期資産,總計 | 1.6 | 0.08494 | |||
物業/廠房/設備,總計 - 淨額 | 0.15 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
流動資産總額 | 10.093 | 14.998 | 20.108 | 11.793 | 16.588 |
現金和短期投資 | 8.839 | 14.064 | 19.339 | 10.537 | 15.718 |
現金等價物 | 8.839 | 14.064 | 19.339 | 10.537 | 15.718 |
應收賬款總額,淨額 | 0.007 | ||||
預付的費用 | 1.254 | 0.934 | 0.769 | 0.756 | 0.363 |
其他流動資産,總計 | 0 | 0 | 0 | 0.5 | 0.5 |
總資産 | 12.798 | 17.718 | 22.343 | 13.543 | 18.853 |
物業/廠房/設備,總計 - 淨額 | 0.105 | 0.12 | 0.135 | 0.15 | 0.165 |
無形資産,淨額 | 0 | ||||
其他長期資産,總計 | 2.6 | 2.6 | 2.1 | 1.6 | 2.1 |
流動負債總額 | 3.24 | 3.438 | 3.001 | 2.78 | 2.533 |
Payable/Accrued | 2.782 | 2.895 | 2.51 | 2.219 | 1.645 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0.503 |
其他流動負債,總計 | 0.458 | 0.543 | 0.491 | 0.561 | 0.385 |
負債總額 | 3.412 | 3.616 | 3.18 | 2.962 | 2.735 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
其他負債,總計 | 0.172 | 0.178 | 0.179 | 0.182 | 0.202 |
股權 | 9.386 | 14.102 | 19.163 | 10.581 | 16.118 |
Preferred Stock - Non Redeemable, Net | 12.554 | 12.801 | 13.675 | 14.931 | 19.726 |
普通股 | 0.049 | 0.049 | 0.048 | 0.033 | 0.032 |
額外實收資本 | 127.67 | 126.781 | 125.074 | 106.821 | 100.828 |
留存收益(累計赤字) | -130.908 | -125.55 | -119.655 | -111.225 | -104.489 |
其他權益,總計 | 0.021 | 0.021 | 0.021 | 0.021 | 0.021 |
總負債和股東權益 | 12.798 | 17.718 | 22.343 | 13.543 | 18.853 |
已發行普通股總數 | 49.306 | 49.013 | 47.974 | 32.74 | 31.764 |
Total Preferred Shares Outstanding | 0.296 | 0.296 | 0.297 | 0.279 | 0.901 |
累計折舊,總計 | -0.015 |
- 每年
- 每季度
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
淨收入/起跑線 | -38.298 | -9.12592 | -8.04822 | -11.1383 | -8.08176 |
經營活動産生的現金 | -18.86 | -7.92752 | -6.32743 | -9.85085 | -8.01907 |
Amortization | 0.002 | 0.00995 | 0.01635 | 0.02453 | 0.01668 |
非現金物品 | 22.057 | 0.70174 | 0.56965 | 0.68542 | 0.52439 |
營運資金的變化 | -2.651 | 0.48671 | 1.13479 | 0.57751 | -0.47838 |
投資活動産生的現金 | 0.964 | 0 | -0.01265 | -0.02096 | |
資本支出 | -0.008 | 0 | -0.01265 | -0.02096 | |
融資活動産生的現金 | 26.041 | 6.60116 | 4.07419 | 9.24948 | 8.46878 |
融資現金流項目 | -0.03 | -0.025 | |||
Total Cash Dividends Paid | -0.008 | -0.00836 | -0.00836 | -0.00836 | -0.00836 |
股票的發行(報廢),淨額 | 26.079 | 6.63452 | 4.08254 | 9.25784 | 8.47713 |
現金淨變化 | 8.145 | -1.32636 | -2.25324 | -0.61402 | 0.42875 |
Cash Taxes Paid | 0 | 0 | 0 | 0 | |
已付現金利息 | 0.03 | 0 | 0 | 0 | 0 |
經營活動産生的現金 | 0.03 | ||||
其他投資現金流量項目,總計 | 0.972 | ||||
債務的發行(退還),淨額 | 0 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -17.215 | -11.859 | -5.966 | -38.298 | -31.566 |
Cash From Operating Activities | -15.4 | -10.177 | -5.073 | -18.86 | -14.171 |
Cash From Operating Activities | 0.045 | 0.03 | 0.015 | 0.03 | 0.015 |
Amortization | 0 | 0 | 0 | 0.002 | 0.002 |
Non-Cash Items | 2.308 | 1.672 | 0.839 | 22.057 | 20.891 |
Cash Taxes Paid | 0 | 0 | |||
Cash Interest Paid | 0 | 0.03 | 0 | ||
Changes in Working Capital | -0.538 | -0.02 | 0.039 | -2.651 | -3.513 |
Cash From Investing Activities | 0 | 0 | 0 | 0.964 | 0.964 |
Capital Expenditures | 0 | -0.008 | -0.008 | ||
Other Investing Cash Flow Items, Total | 0 | 0 | 0 | 0.972 | 0.972 |
Cash From Financing Activities | 13.702 | 13.704 | 13.875 | 26.041 | 26.533 |
Total Cash Dividends Paid | -0.006 | -0.004 | -0.002 | -0.008 | -0.006 |
Issuance (Retirement) of Stock, Net | 13.708 | 13.708 | 13.877 | 26.079 | 26.039 |
Issuance (Retirement) of Debt, Net | 0 | 0 | 0 | 0 | 0.5 |
Net Change in Cash | -1.698 | 3.527 | 8.802 | 8.145 | 13.326 |
Financing Cash Flow Items | -0.03 |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Bio Therapeutic Drugs |
9920 Pacific Heights Blvd, Suite 150
Suite 200
92121
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 580.000 多名交易者,選擇與 Capital.com 交易